Finch Therapeutics - The Microbiome Drug Startup Born Out of OpenBiome
From a nonprofit stool bank that saved patients with chronic C. diff infections, two MIT students spun off a for-profit biotech that went public on Nasdaq — only to watch it collapse just a few years later after rivals beat it to the finish line.
Think & Rich